Strategic Aim: to achieve improved outcomes for children diagnosed with cancer through defining unique disease susceptibilities and exploiting them with novel therapies. Principal InvestigatorsOwen Williams Andy Stoker Kathy Pritchard- Jones David Michod Jasper De Boer John Anderson Karin Straathof Darren Hargrave Sara Ghorashian